Expression of specific matrix metalloproteinases in inflammatory myopathies

被引:83
作者
Kieseier, BC
Schneider, C
Clements, JM
Gearing, AJH
Gold, R
Toyka, KV
Hartung, HP
机构
[1] Graz Univ, Dept Neurol, A-8036 Graz, Austria
[2] Univ Wurzburg, Dept Neurol, D-97070 Wurzburg, Germany
[3] British Biotech Pharmaceut Ltd, Oxford, England
关键词
matrix metalloproteinases; polymyositis; dermatomyositis; inclusion body myositis; muscular dystrophy;
D O I
10.1093/brain/124.2.341
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The family of matrix metalloproteinases (MMPs) comprises endopeptidases that are capable of degrading all extracellular matrix components, Given these actions, it is conceivable that MMPs may play a pathogenic role in inflammatory myopathies, These immune-mediated disorders are characterized by the invasion of mononuclear phagocytes and T lymphocytes and the loss of muscle fibres, We examined whether specific MMPs and their natural inhibitors (tissue inhibitors of metalloproteinases; TIMPs) are expressed in muscle during acute inflammatory attacks by studying muscle biopsies obtained from patients diagnosed as having polymyositis, dermatomyositis, sporadic inclusion body myositis and, for comparison, from cases of various muscular dystrophies. Quantitative polymerase chain reaction analysis revealed significantly elevated mRNA expression of interstitial collagenase (MMP-1) and gelatinase B (MMP-9) in polymyositis and dermatomyositis and to a lesser extent in inclusion body myositis, whereas the level of expression of TIMPs remained unchanged in comparison with controls, Increased mRNA levels were associated with enhanced enzyme expression, as determined by immunoblotting, gelatin zymography and in situ zymography, Immunohistochemically, MMP-1 could be localized around the sarcolemma of diseased muscle fibres and to cells resembling fibroblasts, whereas MMP-9 seemed to be expressed primarily by invading T lymphocytes, Raised levels of MMPs could not be detected in the sera of affected patients, emphasizing the crucial action of MMPs in the inflamed muscle, Our results imply a pathogenic role for specific MMPs in the genesis of inflammatory myopathies, and open new strategies for therapeutic intervention.
引用
收藏
页码:341 / 351
页数:11
相关论文
共 41 条
[1]   PROTEOLYTIC REMODELING OF EXTRACELLULAR-MATRIX [J].
BIRKEDALHANSEN, H .
CURRENT OPINION IN CELL BIOLOGY, 1995, 7 (05) :728-735
[2]   A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells [J].
Black, RA ;
Rauch, CT ;
Kozlosky, CJ ;
Peschon, JJ ;
Slack, JL ;
Wolfson, MF ;
Castner, BJ ;
Stocking, KL ;
Reddy, P ;
Srinivasan, S ;
Nelson, N ;
Boiani, N ;
Schooley, KA ;
Gerhart, M ;
Davis, R ;
Fitzner, JN ;
Johnson, RS ;
Paxton, RJ ;
March, CJ ;
Cerretti, DP .
NATURE, 1997, 385 (6618) :729-733
[3]   Matrix metalloproteinases and TIMPs: properties and implications for the rheumatic diseases [J].
Cawson, T .
MOLECULAR MEDICINE TODAY, 1998, 4 (03) :130-137
[4]   Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies [J].
Choi, YC ;
Dalakas, MC .
NEUROLOGY, 2000, 54 (01) :65-71
[5]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[6]   Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-alpha inhibitor [J].
Clements, JM ;
Cossins, JA ;
Wells, GMA ;
Corkill, DJ ;
Helfrich, K ;
Wood, LM ;
Pigott, R ;
Stabler, G ;
Ward, GA ;
Gearing, AJH ;
Miller, KM .
JOURNAL OF NEUROIMMUNOLOGY, 1997, 74 (1-2) :85-94
[7]   Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system [J].
Cuzner, ML ;
Opdenakker, G .
JOURNAL OF NEUROIMMUNOLOGY, 1999, 94 (1-2) :1-14
[8]   The immunopathologic and inflammatory differences between dermatomyositis, polymyositis and sporadic inclusion body myositis [J].
Dalakas, MC ;
Sivakumar, K .
CURRENT OPINION IN NEUROLOGY, 1996, 9 (03) :235-239
[9]   POLYMYOSITIS, DERMATOMYOSITIS, AND INCLUSION-BODY MYOSITIS [J].
DALAKAS, MC .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (21) :1487-1498
[10]  
DALAKAS MC, 1995, ANN NEUROL, V37, P74